- Home
- CNXC vs SLNO Comparison
CNXC vs SLNO Comparison
Compare CNXC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- SLNO
- Stock Information
- Founded
- CNXC 1991
- SLNO 1999
- Country
- CNXC United States
- SLNO United States
- Employees
- CNXC N/A
- SLNO N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNXC Technology
- SLNO Health Care
- Exchange
- CNXC Nasdaq
- SLNO Nasdaq
- Market Cap
- CNXC 3.3B
- SLNO 3.8B
- IPO Year
- CNXC N/A
- SLNO 2014
- Fundamental
- Price
- CNXC $57.10
- SLNO $56.58
- Analyst Decision
- CNXC Buy
- SLNO Strong Buy
- Analyst Count
- CNXC 4
- SLNO 10
- Target Price
- CNXC $69.50
- SLNO $112.50
- AVG Volume (30 Days)
- CNXC 625.2K
- SLNO 1.8M
- Earning Date
- CNXC 09-25-2025
- SLNO 11-05-2025
- Dividend Yield
- CNXC 2.34%
- SLNO N/A
- EPS Growth
- CNXC N/A
- SLNO N/A
- EPS
- CNXC 3.65
- SLNO N/A
- Revenue
- CNXC $9,625,029,000.00
- SLNO $32,656,999.00
- Revenue This Year
- CNXC $3.62
- SLNO N/A
- Revenue Next Year
- CNXC $3.16
- SLNO $181.85
- P/E Ratio
- CNXC $15.59
- SLNO N/A
- Revenue Growth
- CNXC 11.31
- SLNO N/A
- 52 Week Low
- CNXC $36.28
- SLNO $41.50
- 52 Week High
- CNXC $66.00
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CNXC 64.72
- SLNO 36.98
- Support Level
- CNXC $52.93
- SLNO $48.91
- Resistance Level
- CNXC $57.56
- SLNO $72.99
- Average True Range (ATR)
- CNXC 2.03
- SLNO 4.52
- MACD
- CNXC 0.55
- SLNO -1.00
- Stochastic Oscillator
- CNXC 93.92
- SLNO 31.87
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.